Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
NEW YORK, May 22, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
http://www.reportlinker.com/p0796197/Portal-Hypertension-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2019.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Summary
GlobalData, the industry analysis specialist, has released its new report, "Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Portal Hypertension Therapeutics market. The report identifies the key trends shaping and driving the global Portal Hypertension Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Portal Hypertension Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
The report provides information on the key drivers and challenges of the Portal Hypertension Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Portal Hypertension Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Portal Hypertension Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Portal Hypertension Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Portal Hypertension Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Portal Hypertension Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Portal Hypertension Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global Portal Hypertension Therapeutics market landscape? – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Portal Hypertension Cirrhosis Therapeutics - Introduction 6
2.1 Overview 6
2.2 Portal Venous System 6
2.3 Pathophysiology 7
2.4 Epidemiology 8
2.5 Causes 8
2.6 Child-Pugh Classification of Cirrhosis 10
2.7 Symptoms 11
2.8 Diagnosis 11
2.9 Treatment 12
2.9.1 Variceal hemorrhage 12
2.9.2 Ascites 14
2.10 GlobalData Pipeline Report Guidance 15
3 Portal Hypertension Therapeutics - Market Characterization 16
3.1 Portal Hypertension Therapeutics Market Size (2006-2011) - Global 16
3.2 Portal Hypertension Therapeutics Market Forecast (2011-2019) - Global 17
3.3 Portal Hypertension Therapeutics Market Size (2006-2011) - The US 18
3.4 Portal Hypertension Therapeutics Market Forecast (2011-2019) - The US 19
3.5 Portal Hypertension Therapeutics Market Size (2006-2011) - France 20
3.6 Portal Hypertension Therapeutics Market Forecast (2011-2019) - France 21
3.7 Portal Hypertension Therapeutics Market Size (2006-2011) - Germany 22
3.8 Portal Hypertension Therapeutics Market Forecast (2011-2019) -Germany 23
3.9 Portal Hypertension Therapeutics Market Size (2006-2011) - Italy 24
3.10 Portal Hypertension Therapeutics Market Forecast (2011-2019) - Italy 25
3.11 Portal Hypertension Therapeutics Market Size (2006-2011) - Spain 26
3.12 Portal Hypertension Therapeutics Market Forecast (2011-2019) - Spain 27
3.13 Portal Hypertension Therapeutics Market Size (2006-2011) - The UK 28
3.14 Portal Hypertension Therapeutics Market Forecast (2011-2019) - The UK 29
3.15 Portal Hypertension Therapeutics Market Size (2006-2011) - Japan 30
3.16 Portal Hypertension Therapeutics Market Forecast (2011-2019) - Japan 31
3.17 Drivers and Barriers 32
3.17.1 Drivers for the Portal Hypertension Therapeutics Market 32
3.17.2 Barriers for the Portal Hypertension Therapeutics Market 32
3.18 Opportunity and Unmet Need Analysis 33
3.19 Key Takeaway 34
4 Portal Hypertension Therapeutics - Competitive Assessment 35
4.1 Overview 35
4.1.1 Strategic Competitor Assessment 35
4.2 Product Profile for the Major Marketed Products in the Portal Hypertension Therapeutics Market 36
4.2.1 Beta-Blockers 36
4.2.2 Vasopressin and its Analogs 36
4.2.3 Somatostatin and its Analogs 36
4.3 Key Takeaway 36
5 Portal Hypertension Therapeutics - Pipeline Assessment 37
5.1 Overview 37
5.2 Strategic Pipeline Assessment 37
5.3 Portal Hypertension Therapeutics Pipeline - Pipeline by Clinical Phase of Development 37
5.4 Pipeline Analysis by Phase of Development 38
5.4.1 Portal Hypertension Therapeutics - Phase II/III Pipeline 38
5.4.2 Portal Hypertension Therapeutics - Phase II Pipeline 38
5.5 Technology Trends Analytical Framework 38
5.6 Pipeline by Mechanism of Action 39
5.7 Profiles of Key Late Stage Pipeline Drugs 40
5.7.1 Octreolin (octreotide) 40
5.7.2 Sapropterin (tetrahydrobiopterin) 40
5.7.3 Udenafil (DA-8519) 40
5.8 Key Takeaway 41
6 Portal Hypertension Therapeutics - Clinical Trials Mapping 42
6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 42
6.2 Clinical Trials by Phase 43
6.3 Clinical Trials by Trial Status 44
6.4 Overall Sponsors 45
6.5 Prominent Sponsors 46
6.6 Companies Participating in Therapeutics Clinical Trials 47
7 Portal Hypertension Therapeutics - Strategic Assessment 48
7.1 Portal Hypertension Therapeutics - Implications for Future Market Competition 48
8 Portal Hypertension Therapeutics - Future Players 49
8.1 Introduction 49
8.2 Company Profile 49
8.2.1 Chiasma (Israel) Ltd. 49
8.2.2 Dong-A Pharmaceutical Co Ltd (Dong-A) 50
9 Portal Hypertension Therapeutics - Deals 51
10 Portal Hypertension Therapeutics - Appendix 52
10.1 Market Definitions 52
10.2 Abbreviation 52
10.3 Methodology 53
10.3.1 Coverage 53
10.3.2 Secondary Research 53
10.3.3 Forecasting 54
10.3.4 Primary Research 56
10.3.5 Expert Panel Validation 56
10.4 Contact Us 56
10.5 Disclaimer 56
10.6 Sources 57
List of Tables
Table 1: Child-Pugh Classification of Cirrhosis 10
Table 2: Status Classification of Cirrhosis 11
Table 3: Portal Hypertension Therapeutics Market, Global, Revenue ($bn), 2006-2011 16
Table 4: Portal Hypertension Therapeutics Market, Global, Forecast ($bn), 2011-2019 17
Table 5: Portal Hypertension Therapeutics Market, the US, Revenue ($m), 2006-2011 18
Table 6: Portal Hypertension Therapeutics Market, the US, Forecast ($m), 2011-2019 19
Table 7: Portal Hypertension Therapeutics Market, France, Revenue ($m), 2006-2011 20
Table 8: Portal Hypertension Therapeutics Market, France, Forecast ($m), 2011-2019 21
Table 9: Portal Hypertension Therapeutics Market, Germany, Revenue ($m), 2006-2011 22
Table 10: Portal Hypertension Therapeutics Market, Germany, Forecast ($m), 2011-2019 23
Table 11: Portal Hypertension Therapeutics Market, Italy, Revenue ($m), 2006-2011 24
Table 12: Portal Hypertension Therapeutics Market, Italy, Forecast ($m), 2011-2019 25
Table 13: Portal Hypertension Therapeutics Market, Spain, Revenue ($m), 2006-2011 26
Table 14: Portal Hypertension Therapeutics Market, Spain, Forecast ($m), 2011-2019 27
Table 15: Portal Hypertension Therapeutics Market, the UK, Revenue ($m), 2006-2011 28
Table 16: Portal Hypertension Therapeutics Market, the UK, Forecast ($m), 2011-2019 29
Table 17: Portal Hypertension Therapeutics Market, Japan, Revenue ($m), 2006-2011 30
Table 18: Portal Hypertension Therapeutics Market, Japan, Forecast ($m), 2011-2019 31
Table 19: Portal Hypertension Therapeutics - Phase II/III Pipeline, 2011 38
Table 20: Portal Hypertension Therapeutics - Phase II Pipeline, 2011 38
Table 21: Portal Hypertension Therapeutics - Clinical Trials by Country, 2011 42
Table 22: Portal Hypertension Therapeutics - Clinical Trials by Phase, 2011 43
Table 23: Portal Hypertension Therapeutics - Clinical Trials by Status, 2011 44
Table 24: Portal Hypertension Therapeutics - Overall Sponsors, 2011 45
Table 25: Portal Hypertension Therapeutics - Prominent Sponsors, 2011 46
Table 26: Portal Hypertension Therapeutics - Company Participating in Therapeutics Clinical Trials, 2011 47
Table 27: Portal Hypertension Therapeutics - Pipeline by Company, 2011 49
Table 28: Chiasma (Israel) - Portal Hypertension Therapeutics Pipeline 49
Table 29: Dong-A Pharmaceutical Co., Ltd. - Portal Hypertension Therapeutics Pipeline 50
Table 30: Portal Hypertension Therapeutics, Global, Deals, 2011 51
List of Figures
Figure 1: Portal Venous System 6
Figure 2: Portal Hypertension: Pathophysiology 8
Figure 3: Portal Hypertension: Prehepatic Causes 9
Figure 4: Portal Hypertension: Hepatic Causes 9
Figure 5: Portal Hypertension: Posthepatic Causes 10
Figure 6: Transjugular Intrahepatic Portosystemic Shunt (TIPS) 13
Figure 7: Portal Hypertension Therapeutics Market, Global, Revenue ($bn), 2006-2011 16
Figure 8: Portal Hypertension Therapeutics Market, Global, Forecast ($bn), 2011-2019 17
Figure 9: Portal Hypertension Therapeutics Market, the US, Revenue ($m), 2006-2011 18
Figure 10: Portal Hypertension Therapeutics Market, the US, Forecast ($m), 2011-2019 19
Figure 11: Portal Hypertension Therapeutics Market, France, Revenue ($m), 2006-2011 20
Figure 12: Portal Hypertension Therapeutics Market, France, Forecast ($m), 2011-2019 21
Figure 13: Portal Hypertension Therapeutics Market, Germany, Revenue ($m), 2006-2011 22
Figure 14: Portal Hypertension Therapeutics Market, Germany, Forecast ($m), 2011-2019 23
Figure 15: Portal Hypertension Therapeutics Market, Italy, Revenue ($m), 2006-2011 24
Figure 16: Portal Hypertension Therapeutics Market, Italy, Forecast ($m), 2011-2019 25
Figure 17: Portal Hypertension Therapeutics Market, Spain, Revenue ($m), 2006-2011 26
Figure 18: Portal Hypertension Therapeutics Market, Spain, Forecast ($m), 2011-2019 27
Figure 19: Portal Hypertension Therapeutics Market, the UK, Revenue ($m), 2006-2011 28
Figure 20: Portal Hypertension Therapeutics Market, the UK, Forecast ($m), 2011-2019 29
Figure 21: Portal Hypertension Therapeutics Market, Japan, Revenue ($m), 2006-2011 30
Figure 22: Portal Hypertension Therapeutics Market, Japan, Forecast ($m), 2011-2019 31
Figure 23: Portal Hypertension Therapeutics, Drivers and Restraints, 2011 33
Figure 24: Opportunity and Unmet Need in the Portal Hypertension Therapeutics Market, 2011 34
Figure 25: Portal Hypertension Therapeutics - Strategic Competitor Assessment, 2011 35
Figure 26: Portal Hypertension Therapeutics - Pipeline by Phase of Clinical Development, 2011 37
Figure 27: Portal Hypertension Therapeutics - Technology Trends Analytics Framework, 2011 38
Figure 28: Portal Hypertension Therapeutics - Technology Trends Analytics Framework - Description, 2011 39
Figure 29: Portal Hypertension Therapeutics - Mechanism of Action, 2011 39
Figure 30: Portal Hypertension Therapeutics - Clinical Trials by Country, 2011 42
Figure 31: Portal Hypertension Therapeutics - Clinical Trials by Phase, 2011 43
Figure 32: Portal Hypertension Therapeutics - Clinical Trials by Status, 2011 44
Figure 33: Portal Hypertension Therapeutics - Overall Sponsors, 2011 45
Figure 34: Portal Hypertension Therapeutics - Prominent Sponsors, 2011 46
Figure 35: Portal Hypertension Therapeutics - Company Participating in Therapeutics Clinical Trials, 2011 47
Figure 36: Portal Hypertension Therapeutics - Implications for Future Market Competition, 2011 48
Figure 37: GlobalData Market Forecasting Model 55
Companies mentioned
Chiasma (Israel) Ltd.
Dong-A Pharmaceutical Co Ltd (Dong-A)
To order this report:
Therapy Industry: Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Check our Industry Analysis and Insights
__________________________
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article